Form4insider filings, from the source

SEC Form 4 · accession 0001213900-19-003242

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Chione Ltd
10% Owner
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF1,F2,F3,F4,F5Feb 25, 2019S800,000$4.9936D6,831,267D
COMMON STOCKF1,F2,F3,F4,F5Feb 26, 2019S123,400$5.0017D6,707,867D
COMMON STOCKF1,F2,F3,F4,F5Feb 27, 2019S558,243$4.5067D6,149,624D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit Index Exhibit 24.1 - Power of Attorney, dated February 8, 2019, made by Marcin Czernik and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.2 - Power of Attorney, dated February 8, 2019, made by Andreas Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.3 - Power of Attorney, dated February 8, 2019, made by George Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.4 - Power of Attorney, dated February 8, 2019, made by Wiaczeslaw Smolokowski in favor of Simon Prisk Exhibit (previously filed) 99.1 - Joint Filer Information (filed herewith) Exhibit 99.2 - Joint Filing Agreement (filed herewith). All previously filed exhibits were filed with the Schedule 13G/A of the reporting persons, filed on February 13, 2019.